Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Safety of nerve conduction studies in patients with implantable cardioverter-defibrillators.

Derejko M, Derejko P, Przybylski A, Niewiadomska M, Antczak J, Banach M, Rakowicz M, Szumowski Ł, Walczak F.

Clin Neurophysiol. 2012 Jan;123(1):211-3. doi: 10.1016/j.clinph.2011.06.003. Epub 2011 Jul 1.

PMID:
21723779
[PubMed - indexed for MEDLINE]
2.

Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.

Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B.

Circulation. 2000 Mar 21;101(11):1297-302.

PMID:
10725290
[PubMed - indexed for MEDLINE]
Free Article
3.

Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: eleven-year follow-up of a subset of patients in the Canadian Implantable Defibrillator Study (CIDS).

Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P.

Circulation. 2004 Jul 13;110(2):112-6. Epub 2004 Jul 6.

PMID:
15238454
[PubMed - indexed for MEDLINE]
Free Article
4.

Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) Study.

Steinberg JS, Martins J, Sadanandan S, Goldner B, Menchavez E, Domanski M, Russo A, Tullo N, Hallstrom A; AVID Investigators.

Am Heart J. 2001 Sep;142(3):520-9.

PMID:
11526368
[PubMed - indexed for MEDLINE]
6.

Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.

Kowey PR, Crijns HJ, Aliot EM, Capucci A, Kulakowski P, Radzik D, Roy D, Connolly SJ, Hohnloser SH; ALPHEE Study Investigators.

Circulation. 2011 Dec 13;124(24):2649-60. doi: 10.1161/CIRCULATIONAHA.111.072561. Epub 2011 Nov 14.

PMID:
22082672
[PubMed - indexed for MEDLINE]
Free Article
8.

Japanese randomized trial for investigation of a combined therapy of amiodarone and implantable cardioverter defibrillator in patients with ventricular tachycardia and fibrillation: the Nippon ICD Plus Pharmachologic Option Necessity study design.

Kurita T, Mitamura H, Aizawa Y, Nitta T, Aonuma K, Tsuboi N, Chinushi M, Kobayashi Y, Soejima K, Satomi K, Furushima H, Ohe T, Ogawa S, Kodama I, Ohtsu H, Yamazaki T; (Nippon ICD Plus Pharmachologic Option Necessity (NIPPON) Investigators).

Circ J. 2006 Mar;70(3):316-20.

PMID:
16501299
[PubMed - indexed for MEDLINE]
Free Article
9.

Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.

Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL; AVID Investigators.

J Cardiovasc Electrophysiol. 2003 Sep;14(9):940-8.

PMID:
12950538
[PubMed - indexed for MEDLINE]
10.

Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, Greene HL, Boczor S, Domanski M, Follmann D, Gent M, Roberts RS.

Eur Heart J. 2000 Dec;21(24):2071-8.

PMID:
11102258
[PubMed - indexed for MEDLINE]
Free Article
11.

Lower observed versus expected (based on U.S. age and gender specific rates) survival in patients treated for near-fatal ventricular arrhythmias.

Kulasingam SL, Akiyama T, Mounsey JP, Ledingham R, Hallstrom AP; AVID Investigators.

Pacing Clin Electrophysiol. 2004 Feb;27(2):230-4.

PMID:
14764176
[PubMed - indexed for MEDLINE]
12.
14.

Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".

Böcker D, Breithardt G.

Am J Cardiol. 1999 Mar 11;83(5B):83D-87D. Review.

PMID:
10089846
[PubMed - indexed for MEDLINE]
15.
16.

New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Klein H, Auricchio A, Reek S, Geller C.

Am J Cardiol. 1999 Mar 11;83(5B):91D-97D. Review.

PMID:
10089848
[PubMed - indexed for MEDLINE]
17.

[Canadian Implantable Defibrillator Study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone].

Della Bella P.

Ital Heart J Suppl. 2000 Aug;1(8):1070-1. Italian. No abstract available.

PMID:
10993020
[PubMed - indexed for MEDLINE]
18.

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.

J Am Coll Cardiol. 1999 May;33(6):1596-601.

PMID:
10334430
[PubMed - indexed for MEDLINE]
Free Article
19.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
[PubMed - indexed for MEDLINE]
20.

The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.

Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.

Europace. 2004 Jul;6(4):257-66.

PMID:
15172648
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk